BRU : IBAB.BR

Ion Beam Applications S.A.

$16.4 EUR

$0.32 (1.99%)

Volume
8.97K
Average Volume
34.6K
Market Capitalization
$480.98M
P/E Ratio
37.88
Dividend Yield
1.07%
Price Target
Year High
$17.76
Year Low
$9.90
Day High
—
Day Low
—
Payout Ratio
$0.56
Current Ratio
$0.99
Company Overview

BRU

Olivier Legrain

Medical - Devices

Healthcare

IBAB.BR

2118

BE

EUR

https://www.iba-worldwide.com

32 1 047 58 11

B5317W146

N/A

Liquidity Metrics

0.92

0.99

0.71

0.14

0.56

Sales & Valuation

$620.2M

0.78

3.80

-13.71

-1.19

Profitability

$0.43

$12.7M

2.04%

3.03%

10.28%

1.83%

P/E Metrics

37.88

0.87

0.87

Analyst Price Target & Rating

Neutral

3/5

0 Analysts

%

Financial Health Scores

2.41

4/9

-$3.1M

$690.6M

$563.4M

$38.7M

Key Metrics (TTM)

No key metrics data available.

Company Executives
Name Title
Bruno Scutnaire President of IBA RadioPharma Solutions
Henri de Romree Deputy Chief Executive Officer, Internal Director & Managing Director
Yves Jongen Founder, Chief Research Officer & Executive Director
Catherine Vandenborre CFO, Chief Ventures & Corporate Officer
Thomas Canon Sustainability Program Director
Olivier Legrain CEO, MD & Vice Chairman
Olivier Lechien Corporate Communication Director
Poll Results

No votes yet today — be the first to share your view!

About Ion Beam Applications S.A. (BRU:IBAB.BR) Stock

Ion Beam Applications S.A. (IBA) specializes in the creation, production, and maintenance of advanced medical equipment and software systems designed to combat cancer, operating across Belgium, the United States, and numerous other countries. Its operations are structured into two key divisions: Proton Therapy and Other Accelerators, and Dosimetry. The Proton Therapy and Other Accelerators segment is dedicated to the engineering, manufacturing, and upkeep of both clinical and industrial particle accelerators, including cutting-edge proton therapy apparatus. This division also furnishes comprehensive, ready-to-use systems for treating cancer with proton beams, a range of cyclotrons crucial for generating radioisotopes for PET and SPECT imaging, as well as industrial accelerators employed in ... sterilization and ionization processes. The Dosimetry segment offers instruments and expertise aimed at improving the precision and reducing errors in radiation therapy, medical imaging quality assurance, and calibration. IBA maintains a crucial research and development alliance with the Belgian nuclear research center, SCK CEN, to facilitate the development of Actinium-225 (225Ac), an innovative radioisotope with potential in cancer therapy, and collaborates with the University of Pennsylvania on pioneering research into ConformalFLASH technology. Established in 1986, the company's headquarters are located in Louvain-la-Neuve, Belgium.

Frequently Asked Questions

What is the current Ion Beam Applications S.A. (IBAB.BR) stock price?

Ion Beam Applications S.A.(BRU:IBAB.BR) stock price is $16.4 in the last trading session. During the trading session, IBAB.BR stock reached the peak price of $17.76 while $9.9 was the lowest point it dropped to. The percentage change in IBAB.BR stock occurred in the recent session was 1.99% while the dollar amount for the price change in IBAB.BR stock was $0.32.

IBAB.BR's industry and sector of operation?

The BRU listed IBAB.BR is part of Medical - Devices industry that operates in the broader Healthcare sector.

Who are the executives of IBAB.BR?

Bruno Scutnaire | President of IBA RadioPharma Solutions
Henri de Romree | Deputy Chief Executive Officer, Internal Director & Managing Director
Yves Jongen | Founder, Chief Research Officer & Executive Director
Catherine Vandenborre | CFO, Chief Ventures & Corporate Officer
Thomas Canon | Sustainability Program Director

How many employees does IBAB.BR have?

Number of IBAB.BR employees currently stands at 2118. IBAB.BR operates from 3, Chemin du Cyclotron, Louvain-la-Neuve, BU 1348, BE.

Link for IBAB.BR official website?

Official Website of IBAB.BR is: https://www.iba-worldwide.com

How do I contact IBAB.BR?

IBAB.BR could be contacted at phone #32 1 047 58 11 and can also be accessed through its website. IBAB.BR operates from 3, Chemin du Cyclotron, Louvain-la-Neuve, BU 1348, BE.

How many shares of IBAB.BR are traded daily?

The average number of IBAB.BR shares traded daily for last 3 months was 34.6K.

What is the market cap of IBAB.BR currently?

The market value of IBAB.BR currently stands at $480.98M with its latest stock price at $16.4